Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma
Differentiated thyroid carcinoma (DTC) comprises over 90% of thyroid tumors and includes papillary and follicular carcinomas. Patients with DTC have an excellent prognosis, with a 10-year survival rate of over 90%. However, the risk of recurrent tumor ranges between 5% and 30% within 10 years of the...
Main Authors: | Shorook Na’ara, Moran Amit, Eran Fridman, Ziv Gil |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2016-01-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=546 |
Similar Items
-
Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
by: Mayara Peres Barbosa, et al. -
Evaluation of lymph node ratio and morphologic patterns of nodal reactive hyperplasia in primary organ malignancy
by: Shinde V Sweety, et al.
Published: (2019-01-01) -
Persistent and recurrent disease in patients with papillary thyroid carcinoma with clinically apparent (cN1), but not extensive, lymph node involvement and without other factors for poor prognosis
by: Mariana de Souza Furtado, et al. -
Predictors of metastasis to lymph nodes posterior to the right recurrent laryngeal nerve in differentiated thyroid carcinoma: A prospective study
by: Ziwen Liu, et al.
Published: (2017-07-01) -
SENTINEL LYMPH NODE CONCEPT IN DIFFERENTIATED THYROID CANCER
by: Markovic Ivan, et al.
Published: (2014-12-01)